WO2004079751A2 - Method for producing actinium-225 - Google Patents

Method for producing actinium-225 Download PDF

Info

Publication number
WO2004079751A2
WO2004079751A2 PCT/EP2004/050260 EP2004050260W WO2004079751A2 WO 2004079751 A2 WO2004079751 A2 WO 2004079751A2 EP 2004050260 W EP2004050260 W EP 2004050260W WO 2004079751 A2 WO2004079751 A2 WO 2004079751A2
Authority
WO
WIPO (PCT)
Prior art keywords
target
deuterons
irradiation
mev
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/050260
Other languages
French (fr)
Other versions
WO2004079751A3 (en
Inventor
Kamel Abbas
Christos Apostolidis
Willem Janssens
Hermann Stamm
Tuomo Nikula
Ramon Carlos Marquez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
European Community EC Belgium
Original Assignee
European Community EC Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by European Community EC Belgium filed Critical European Community EC Belgium
Priority to CA002516697A priority Critical patent/CA2516697A1/en
Priority to US10/548,608 priority patent/US20060198772A1/en
Priority to EP04717650A priority patent/EP1599882B1/en
Priority to AU2004217388A priority patent/AU2004217388B2/en
Priority to DE602004003683T priority patent/DE602004003683T2/en
Priority to PL04717650T priority patent/PL1599882T3/en
Publication of WO2004079751A2 publication Critical patent/WO2004079751A2/en
Publication of WO2004079751A3 publication Critical patent/WO2004079751A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05HPLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H6/00Targets for producing nuclear reactions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/10Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00Radioactive sources
    • G21G4/04Radioactive sources other than neutron sources
    • G21G4/06Radioactive sources other than neutron sources characterised by constructional features
    • G21G4/08Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application

Definitions

  • the present invention generally relates to a method for producing Actm- ⁇ um-225
  • Act ⁇ n ⁇ um-225 (Ac-225) and its daughter B ⁇ smuth-213 (Bi- 213) is of great interest for cancer therapy, as they constitute preferred ra- dionuclides for alpha-immunotherapy purposes Indeed, to selectively irradiate cancer cells, alpha-immunotherapy uses alpha-emitters such as B ⁇ -213 and possibly Ac-225 that are linked, through a bifunctional chelator, to monoclonal antibodies or peptides
  • EP-A-0 962 942 discloses a method for producing Ac-225, which consists in irradiating a target containing Ra-226 with protons in a cyclotron, so that metastable radionuclei are transformed into Actinium by emitting neutrons It is to be noted that this method allows to obtain the desired Ac-225, but also considerable quantities of other highly undesired radionuc des, especially Ac- 224 and Ac-226 In order to eliminate these undesired radionuclides, the post- irradiation process is delayed since Ac-224 and Ac-226 present a relatively short half-life compared with Ac-225 (half-life 10 days) This waiting period however also leads to a considerable loss of Ac-225
  • EP-A-0 962 942 proposes to irradiate a target of Ra-226 with protons having an incident energy of between 10 and 20 MeV, preferably of about 15 MeV
  • the object of the present invention is to provide an improved method of producing Ac-225, which provides higher yield of Ac-225 This object is achieved by a method as claimed in claim 1.
  • Actimium-225 is produced by irradiating a target of Radium-226 with deuterons.
  • the present method is based on the transformation of instable Ra-226 radionuclei -due to deuteron bombardment- into Ac-225 by emitting neutrons (this reaction is hereinafter noted Ra- 226(d,3n)Ac-225). It has been found that reaction Ra-226(d,3n)Ac-225 has a higher cross-section -i.e. has a greater likelihood to occur- than the conventionally used reaction involving proton bombardment of Ra-226. It follows that the method of the invention permits production of Ac-225 at higher yields than the conventional method. It is further to be noted that the present method also allows production of Ac-225 at high purity levels, which is important for therapeutic use. The present method is thus particularly well adapted for producing Ac-225 in view of Bi-213 generation.
  • the deuterons are preferably bombarded on the target of Ra-226 with an incident energy of between 15 and 22 MeV, at which Ac-225 can be produced with high yields and purity levels.
  • a more preferred energy range for the deuterons is between 18 and 20 MeV, since it provides the optimal Ac-225 production yields and purity levels.
  • the production yield of Ac-225 is increased by up to 36% when compared to the conventional method described in EP-A-0 962 942.
  • the present process is preferably carried out in a cyclotron, which generally permits to accelerate deuterons to the preferred energy range.
  • the Ra-226 target material preferably is in the form RaCI 2 , which has been dried and pressed into pellets.
  • the latter is advantageously placed in a sealed capsule of aluminium.
  • the capsule provides a leak-free container for the highly toxic Ra-226 and allows target processing after irradiation while preventing introduction of impurities into the medical grade product and avoids the introduction of undesired cations which would interfere with the chelation of the radionuclides.
  • the target material Before introduction into the capsule, the target material is preferably placed in an envelope made of Ag, Ti or Nb, so as to avoid contamination of the target material with aluminium, in particular during post-irradiation treatments.
  • These metals have a high conductivity and thus allow for a high deuteron current density during irradiation.
  • Nb is particularly preferred for its low ionising radiation emissions after irradiation.
  • Actinium is preferably chemically separated from the irradiated target of Ra-226.
  • FIG.1 is a graph illustrating the crass-section of reactions Ra-226(d,3n)Ac- 225 and Ra-226(p,2n)Ac-225 in function of the incident beam energy;
  • FIG.2 is a graph illustrating the reaction cross-sections corresponding to the different Ac radionuclides in function of the deuteron energy.
  • Ac-225 is produced by bombardment of Ra-226 with deuterons.
  • Ac-225 results from the transformation of the Ra-226 -due to deuteron bombardment- with emission of three neutrons; this nuclear reaction is noted Ra-226(d,3n)Ac-225.
  • the present method has been found to produce Ac-225 with a higher level of purity and higher yield than the method used up to now based on the reaction of Ra-226 with protons (noted Ra-226(p,2n)Ac-225) as known e.g. from EP-A-0 962942.
  • the cross-section is a numerical quantity (unit: barn) that represents the likelihood that a given atomic nucleus will undergo a specific reaction in relation to a particular species of incident particle
  • the cross-section of the reaction used in the present method is much higher than that of the conventional reaction (proton bombardment), over a large part of the energy range
  • the present method thus provides an improved method of producing Ac- 225, which, when implemented with deuterons of adequate energy, provides increased yields and purity levels
  • the present method is preferably implemented as follows Firstly, Ra-226 target material is prepared, preferably in the form RaCl 2 by precipitation out of concentrated HCI This target matenal is then heated to a temperature of about 150 to 200°C to release the crystal water therefrom and pressed into pellets
  • the target material which thus essentially consists of RaCI 2
  • an envelope preferably made of Ag, Ti or Nb
  • These metals are insoluble in HCI and have a high thermal conductivity, which allows for a high current density during deuteron irradiation
  • Nb has the advantage of being less activated by the irradiation than Ag or Ti, thus resulting in a lower ionising radiation emission rate from the envelope
  • the Ra-226 target material received in its envelope is then sealed in a capsule made of aluminium It is to be noted that the previous elimination of crystal water from the RaCI 2 will avoid pressure build up in the capsule.
  • the capsule provides a sealed container for the highly radiotoxic Ra-226, allows target processing after irradiation without introducing impurities into the medical grade product and avoids the Introduction of undesired cations that would interfere with the chelation of the radionuclides in the later therapeutic applications.
  • the Ra-226 target received in its envelope and in the capsule, is irradiated by a beam of deuterons.
  • the deuteron beam is preferably produced by cyclotron, wherein deuterons can generally be accelerated to the preferred energy range.
  • the capsule is advantageously cooled by a closed water circuit with an alpha monitor to detect any leakage of radon from the capsule.
  • a cooling circuit comprises e.g. a pump and a heat exchanger for extracting the heat produced by the irradiation in the capsule.
  • the target material is dissolved and then treated in a conventional way to separate Ac from Ra, e.g. an ion exchangers.
  • Table 1 In table 1 , calculated relative yields for Ac-225 and its other isotopes Ac- 224, Ac-226 and Ac-227 are indicated when produced with the present process or with the conventional process using protons These values have been calculated for two scenarios (1) after irradiation with the selected particle beam for 10 hours, and (2) after irradiation with the selected particle beam for 10 hours and 20 hours cooling As can be seen, the Ac-225 yield obtained by bombarding Ra-226 with a 19 MeV deuterons beam is in both scenarios about 36% higher than the yield obtained with the conventional method

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plasma & Fusion (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Particle Accelerators (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

A method for producing Ac-225 is presented, wherein Ac-225 is produced by bombardment of Ra-226 with deuterons accelerated in a cyclotron. The deuterons preferably have an incident energy of between 15 and 22 MeV. The method, which allows production of Ac-225 at high yields and purity levels, is particularly interesting in view of Bi-213 generation.

Description

METHOD FOR PRODUCING ACTINIUM-225
FIELD OF THE INVENTION
The present invention generally relates to a method for producing Actm- ιum-225
BACKGROUND OF THE INVENTION
Production of Actιnιum-225 (Ac-225) and its daughter Bιsmuth-213 (Bi- 213) is of great interest for cancer therapy, as they constitute preferred ra- dionuclides for alpha-immunotherapy purposes Indeed, to selectively irradiate cancer cells, alpha-immunotherapy uses alpha-emitters such as Bι-213 and possibly Ac-225 that are linked, through a bifunctional chelator, to monoclonal antibodies or peptides
EP-A-0 962 942 discloses a method for producing Ac-225, which consists in irradiating a target containing Ra-226 with protons in a cyclotron, so that metastable radionuclei are transformed into Actinium by emitting neutrons It is to be noted that this method allows to obtain the desired Ac-225, but also considerable quantities of other highly undesired radionuc des, especially Ac- 224 and Ac-226 In order to eliminate these undesired radionuclides, the post- irradiation process is delayed since Ac-224 and Ac-226 present a relatively short half-life compared with Ac-225 (half-life 10 days) This waiting period however also leads to a considerable loss of Ac-225
In order to increase the yield of Ac-225, EP-A-0 962 942 proposes to irradiate a target of Ra-226 with protons having an incident energy of between 10 and 20 MeV, preferably of about 15 MeV
OBJECT OF THE INVENTION
The object of the present invention is to provide an improved method of producing Ac-225, which provides higher yield of Ac-225 This object is achieved by a method as claimed in claim 1.
SUMMARY OF THE INVENTION
According to the present invention, Actimium-225 is produced by irradiating a target of Radium-226 with deuterons. The present method is based on the transformation of instable Ra-226 radionuclei -due to deuteron bombardment- into Ac-225 by emitting neutrons (this reaction is hereinafter noted Ra- 226(d,3n)Ac-225). It has been found that reaction Ra-226(d,3n)Ac-225 has a higher cross-section -i.e. has a greater likelihood to occur- than the conventionally used reaction involving proton bombardment of Ra-226. It follows that the method of the invention permits production of Ac-225 at higher yields than the conventional method. It is further to be noted that the present method also allows production of Ac-225 at high purity levels, which is important for therapeutic use. The present method is thus particularly well adapted for producing Ac-225 in view of Bi-213 generation.
The deuterons are preferably bombarded on the target of Ra-226 with an incident energy of between 15 and 22 MeV, at which Ac-225 can be produced with high yields and purity levels. A more preferred energy range for the deuterons is between 18 and 20 MeV, since it provides the optimal Ac-225 production yields and purity levels. At 19 MeV, the production yield of Ac-225 is increased by up to 36% when compared to the conventional method described in EP-A-0 962 942.
In practice, the present process is preferably carried out in a cyclotron, which generally permits to accelerate deuterons to the preferred energy range.
The Ra-226 target material preferably is in the form RaCI2, which has been dried and pressed into pellets. To facilitate the handling of the highly toxic Ra-226 target material, the latter is advantageously placed in a sealed capsule of aluminium. The capsule provides a leak-free container for the highly toxic Ra-226 and allows target processing after irradiation while preventing introduction of impurities into the medical grade product and avoids the introduction of undesired cations which would interfere with the chelation of the radionuclides.
Before introduction into the capsule, the target material is preferably placed in an envelope made of Ag, Ti or Nb, so as to avoid contamination of the target material with aluminium, in particular during post-irradiation treatments. These metals have a high conductivity and thus allow for a high deuteron current density during irradiation. Nb is particularly preferred for its low ionising radiation emissions after irradiation.
After irradiation, Actinium is preferably chemically separated from the irradiated target of Ra-226.
BRIEF DESCRIPTION OF THE DRAWINGS The present invention will now be described, by way of example, with reference to the accompanying drawings, in which:
FIG.1 : is a graph illustrating the crass-section of reactions Ra-226(d,3n)Ac- 225 and Ra-226(p,2n)Ac-225 in function of the incident beam energy;
FIG.2: is a graph illustrating the reaction cross-sections corresponding to the different Ac radionuclides in function of the deuteron energy.
DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
According to the present method Ac-225 is produced by bombardment of Ra-226 with deuterons. As already explained, Ac-225 results from the transformation of the Ra-226 -due to deuteron bombardment- with emission of three neutrons; this nuclear reaction is noted Ra-226(d,3n)Ac-225. The present method has been found to produce Ac-225 with a higher level of purity and higher yield than the method used up to now based on the reaction of Ra-226 with protons (noted Ra-226(p,2n)Ac-225) as known e.g. from EP-A-0 962942.
In Fig.1 , which was obtained by Monte Carlo simulation, the reaction cross-section for the present reaction (Ra-226(d,3n)Ac-225) and for the known reaction (Ra-226(p,2n)-Ac225) are plotted in function of the energy of the incident particle beam. The cross-section is a numerical quantity (unit: barn) that represents the likelihood that a given atomic nucleus will undergo a specific reaction in relation to a particular species of incident particle As can be seen, the cross-section of the reaction used in the present method is much higher than that of the conventional reaction (proton bombardment), over a large part of the energy range It follows that Ac-225 production according to the present method will provide higher yields than the proton irradiation method, in particular in the preferred deuteron energy range of 15 to 22 MeV The optimal yields will be obtained with a deuteron energy of between 18 and 20 MeV
The bombardment of Ra-226 with deuterons also leads to the production of radionuclides other than Ac-225, but in lower quantities In Fig 2, the reaction cross-section of Ra-226 bombardment with deuterons to produce Ac-225 and its isotopes Ac-224, Ac-226 and Ac-227 is plotted versus the deuteron energy As can be seen, in the preferred energy range of 15 to 22 MeV, the cross- section of Ra-226(d,3n)Ac-225 is largely above the cross-sections of the other Ac radionuclides
The present method thus provides an improved method of producing Ac- 225, which, when implemented with deuterons of adequate energy, provides increased yields and purity levels
In practice, the present method is preferably implemented as follows Firstly, Ra-226 target material is prepared, preferably in the form RaCl2 by precipitation out of concentrated HCI This target matenal is then heated to a temperature of about 150 to 200°C to release the crystal water therefrom and pressed into pellets
Next, the target material, which thus essentially consists of RaCI2, is intro- duced into an envelope preferably made of Ag, Ti or Nb These metals are insoluble in HCI and have a high thermal conductivity, which allows for a high current density during deuteron irradiation In addition, Nb has the advantage of being less activated by the irradiation than Ag or Ti, thus resulting in a lower ionising radiation emission rate from the envelope The Ra-226 target material received in its envelope is then sealed in a capsule made of aluminium It is to be noted that the previous elimination of crystal water from the RaCI2 will avoid pressure build up in the capsule. The capsule provides a sealed container for the highly radiotoxic Ra-226, allows target processing after irradiation without introducing impurities into the medical grade product and avoids the Introduction of undesired cations that would interfere with the chelation of the radionuclides in the later therapeutic applications.
According to the present method, the Ra-226 target, received in its envelope and in the capsule, is irradiated by a beam of deuterons. The deuteron beam is preferably produced by cyclotron, wherein deuterons can generally be accelerated to the preferred energy range. During irradiation, the capsule is advantageously cooled by a closed water circuit with an alpha monitor to detect any leakage of radon from the capsule. Such a cooling circuit comprises e.g. a pump and a heat exchanger for extracting the heat produced by the irradiation in the capsule.
After irradiation, the target material is dissolved and then treated in a conventional way to separate Ac from Ra, e.g. an ion exchangers.
Figure imgf000006_0001
Table 1 In table 1 , calculated relative yields for Ac-225 and its other isotopes Ac- 224, Ac-226 and Ac-227 are indicated when produced with the present process or with the conventional process using protons These values have been calculated for two scenarios (1) after irradiation with the selected particle beam for 10 hours, and (2) after irradiation with the selected particle beam for 10 hours and 20 hours cooling As can be seen, the Ac-225 yield obtained by bombarding Ra-226 with a 19 MeV deuterons beam is in both scenarios about 36% higher than the yield obtained with the conventional method
This table also shows that the long-life Ac-227 is produced in extremely low quantity with respect to Ac-225 Due to their relatively short half-life, the other radionuclides Ac-224 and Ac-226 are rapidly eliminated by natural decay

Claims

Claims A method for producing Ac-225 characterised by irradiating a target of Radιum-226 with deuterons The method according to claim 1 , characterised in that said deuterons have an incident energy of between 15 and 22 MeV, preferably between 18 and 20 MeV The method according to claim 1 or 2, characterised in that said deuterons are accelerated in a cyclotron The method according to any one of claims 1 to 3, characterised in that said target of Ra-226 is in the form of pellets consisting essentially of radium chloride RaCI2 The method according to any one of the preceding claims, characterised in that during said irradiation, said target is received in a sealed capsule made of aluminium, which is cooled by a closed cooling circuit The method according to claim 5, characterised in that before introduction into said capsule, said target of Ra-226 is placed in an envelope made of
Ag, Ti or Nb The method according to claim 1 , characterised in that after irradiation, Actinium is chemically separated from the irradiated target of Ra-226
PCT/EP2004/050260 2003-03-06 2004-03-05 Method for producing actinium-225 Ceased WO2004079751A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002516697A CA2516697A1 (en) 2003-03-06 2004-03-05 Method for producing actinium-225
US10/548,608 US20060198772A1 (en) 2003-03-06 2004-03-05 Method for producing actinium-225
EP04717650A EP1599882B1 (en) 2003-03-06 2004-03-05 Method for producing actinium-225
AU2004217388A AU2004217388B2 (en) 2003-03-06 2004-03-05 Method for producing Actinium-225
DE602004003683T DE602004003683T2 (en) 2003-03-06 2004-03-05 PROCESS FOR PREPARING ACTINIUM-225
PL04717650T PL1599882T3 (en) 2003-03-06 2004-03-05 Method for producing actinium-225

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03100558.0 2003-03-06
EP03100558A EP1455364A1 (en) 2003-03-06 2003-03-06 Method for producing actinium-225

Publications (2)

Publication Number Publication Date
WO2004079751A2 true WO2004079751A2 (en) 2004-09-16
WO2004079751A3 WO2004079751A3 (en) 2004-12-09

Family

ID=32799014

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/050260 Ceased WO2004079751A2 (en) 2003-03-06 2004-03-05 Method for producing actinium-225

Country Status (8)

Country Link
US (1) US20060198772A1 (en)
EP (2) EP1455364A1 (en)
AT (1) ATE348391T1 (en)
AU (1) AU2004217388B2 (en)
CA (1) CA2516697A1 (en)
DE (1) DE602004003683T2 (en)
PL (1) PL1599882T3 (en)
WO (1) WO2004079751A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020277276B1 (en) * 2019-11-29 2021-02-04 Ion Beam Applications A METHOD FOR PRODUCING Ac-225 FROM Ra-226
WO2025253128A1 (en) 2024-06-08 2025-12-11 Astral Neutronics Ltd Improvements in and relating to nuclear fusion reactor systems
WO2025253127A1 (en) 2024-06-08 2025-12-11 Astral Neutronics Ltd Improvements in and relating to isotope production

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9202602B2 (en) 2010-02-10 2015-12-01 Uchicago Argonne, Llc Production of isotopes using high power proton beams
US11798700B2 (en) 2018-03-26 2023-10-24 The University Of British Columbia Systems, apparatus and methods for separating actinium, radium, and thorium
CN113939885A (en) * 2019-04-08 2022-01-14 加利福尼亚大学董事会 System and method for making actinium-225
WO2020260210A1 (en) 2019-06-25 2020-12-30 The European Union, Represented By The European Commission Method for producing 225actinium from 226radium
KR102211812B1 (en) 2019-07-23 2021-02-04 한국원자력의학원 The method of producing actinium by liquified radium
KR102233112B1 (en) 2019-07-25 2021-03-29 한국원자력의학원 The apparatus of producing nuclide using fluid target
EP3800648A1 (en) * 2019-10-04 2021-04-07 Sck Cen Methods and systems for the production of isotopes
CN112614607A (en) * 2020-12-02 2021-04-06 中广核研究院有限公司 Preparation method of radionuclide manganese-54

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1084926A (en) * 1952-10-15 1955-01-25 Philips Nv Process for preparing radioactive products from a metal or an alloy made radioactive by a nuclear reaction
LU87684A1 (en) * 1990-02-23 1991-10-08 Euratom METHOD FOR PRODUCING ACTINIUM-225 AND WISMUT-213
US5392319A (en) * 1992-12-22 1995-02-21 Eggers & Associates, Inc. Accelerator-based neutron irradiation
US5468355A (en) * 1993-06-04 1995-11-21 Science Research Laboratory Method for producing radioisotopes
LU88636A1 (en) * 1995-07-03 1997-01-03 Euratom Process for the production of Actinium-225
LU88637A1 (en) * 1995-07-03 1997-01-03 Euratom Process for the production of actinium-225 and bismuth-213 by irradiation of radium-226 with high-energy gamma quanta
DK0962942T3 (en) * 1998-06-02 2003-07-07 Europ Economic Community Process for the production of Ac-225 by irradiation of Ra-226 with protons
RU2260217C2 (en) * 1999-11-30 2005-09-10 Скотт ШЕНТЕР Method for production of the actinium-225 and its daughter elements

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020277276B1 (en) * 2019-11-29 2021-02-04 Ion Beam Applications A METHOD FOR PRODUCING Ac-225 FROM Ra-226
WO2025253128A1 (en) 2024-06-08 2025-12-11 Astral Neutronics Ltd Improvements in and relating to nuclear fusion reactor systems
WO2025253127A1 (en) 2024-06-08 2025-12-11 Astral Neutronics Ltd Improvements in and relating to isotope production

Also Published As

Publication number Publication date
CA2516697A1 (en) 2004-09-16
US20060198772A1 (en) 2006-09-07
EP1599882B1 (en) 2006-12-13
DE602004003683T2 (en) 2007-10-25
DE602004003683D1 (en) 2007-01-25
AU2004217388A1 (en) 2004-09-16
EP1455364A1 (en) 2004-09-08
EP1599882A2 (en) 2005-11-30
WO2004079751A3 (en) 2004-12-09
ATE348391T1 (en) 2007-01-15
PL1599882T3 (en) 2007-05-31
AU2004217388B2 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
CA2331211C (en) Method for producing ac-225 by irradiation of ra-226 with protons
EP3991184B1 (en) Method for producing 225actinium from 226radium
US20080240330A1 (en) Compact Device for Dual Transmutation for Isotope Production Permitting Production of Positron Emitters, Beta Emitters and Alpha Emitters Using Energetic Electrons
AU2004217388B2 (en) Method for producing Actinium-225
EP3953949B1 (en) Systems and methods for producing actinium-225
WO2006028620A2 (en) Medical radioisotopes and methods for producing the same
CN115552548A (en) Equipment for producing actinium-225 by radium-226 and application thereof
Grundler et al. The metamorphosis of radionuclide production and development at Paul Scherrer Institute
Shusterman et al. Aqueous harvesting of Zr 88 at a radioactive-ion-beam facility for cross-section measurements
EP1610346A1 (en) Method for producing actinium-225
EP3847675B1 (en) Process for the production of gallium radionuclides
Ermolaev et al. Production of no-carrier-added 117m Sn from proton irradiated antimony
US7510691B2 (en) Method for improving the recovery of cesium-131 from barium carbonate
JP7398804B2 (en) Method of producing actinium-225
Alfassi et al. A new alpha-emitter for nuclear medicine: 230 U
Kambali et al. Spectral Analysis of Proton-Irradiated Natural MoO 3 Relevant for Technetium-99m Radionuclide Production.
Wibowo et al. Calculated cyclotron-based scandium-47 production yields via 48Ca (p, 2n) 47Sc nuclear reaction
EP1453063A1 (en) Method for producing actinium-225
RU2841999C1 (en) Method of producing radioisotopes terbium-155, terbium-152, terbium-149 and strontium-82
Egamediev et al. Application of modified aluminium oxide for gallium-67 separation from natural zinc target
WO2024003344A1 (en) Production of the radionuclide lanthanum-135
Petrusenko et al. Estimation of palladium-103 radionuclide producibility at the cyclotron CV-28 for nuclear medicine
Li tral Analy ant for Te
O’Neil et al. New solid and gas phase targets for the CTI RDS 111 cyclotron
Lepera PRODUCTION OF 61 CU BY DEUTERON IRRADIATION OF NATURAL NI

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2516697

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004717650

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004217388

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004217388

Country of ref document: AU

Date of ref document: 20040305

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004217388

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004717650

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10548608

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10548608

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2004717650

Country of ref document: EP